Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments. | FEBS Lett | 2020 | 31468514 | PubTator, text mining | PubMed |
| Survey of ribose ring pucker of signaling nucleosides and nucleotides. | Nucleosides Nucleotides Nucleic Acids | 2020 | 31460850 | PubTator, text mining | PubMed |
| Sperm and Seminal Plasma Proteomics: Molecular Changes Associated with Varicocele-Mediated Male Infertility. | World J Mens Health | 2020 | 31385477 | PubTator, text mining | PubMed |
SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. | Histopathology | 2020 | 31233624 | PubTator, text mining | PubMed |
| CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. | Acta Clin Croat | 2019 | 34975203 | PubTator, text mining | PubMed |
| Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment. | Pan Afr Med J | 2019 | 33708294 | PubTator, text mining | PubMed |
| HIV and SIV in Body Fluids: From Breast Milk to the Genitourinary Tract. | Curr Immunol Rev | 2019 | 33312088 | PubTator, text mining | PubMed |
| The dendritic cell tool for oral cancer treatment. | J Oral Maxillofac Pathol | 2019 | 31942108 | PubTator, text mining | PubMed |
| Post-Brachytherapy Transformation of Prostatic Adenocarcinoma to Squamous Cell Carcinoma: A Cadaver Anatomy Case Report. | Cureus | 2019 | 31890390 | PubTator, text mining | PubMed |
| Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System. | J Pharm Health Care Sci | 2019 | 31890238 | PubTator, text mining | PubMed |
| Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. | PLoS One | 2019 | 31877167 | PubTator, text mining | PubMed |
| The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases. | Cancer Control | 2019 | 31865766 | PubTator, text mining | PubMed |
| High Levels of Glutaminase II Pathway Enzymes in Normal and Cancerous Prostate Suggest a Role in 'Glutamine Addiction'. | Biomolecules | 2019 | 31861280 | PubTator, text mining | PubMed |
| Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine. | Cancers (Basel) | 2019 | 31835327 | PubTator, text mining | PubMed |
| Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN® in combination with chemotherapy. | Future Sci OA | 2019 | 31827897 | PubTator, text mining | PubMed |
| How Prostate Cancer Cells Use Strategy Instead of Brute Force to Achieve Metastasis. | Cancers (Basel) | 2019 | 31817000 | PubTator, text mining | PubMed |
| Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism. | J Clin Med | 2019 | 31816910 | PubTator, text mining | PubMed |
| Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? | J Immunother Cancer | 2019 | 31775882 | PubTator, text mining | PubMed |
| SANTAVACTM: Summary of Research and Development. | Vaccines (Basel) | 2019 | 31744189 | PubTator, text mining | PubMed |
| Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence. | Oncotarget | 2019 | 31741711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=41